Medicare Enrolled

Dr. Rumpa Amornmarn, MD

Radiology - Diagnostic · Kissimmee, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
737 WEST OAK STREET, Kissimmee, FL 34741
4079332775
In practice since 2006 (20 years)
NPI: 1093783235 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Amornmarn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amornmarn? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Amornmarn

Dr. Rumpa Amornmarn is a radiology - diagnostic specialist in Kissimmee, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Amornmarn performed 15 Medicare services across 11 unique beneficiaries.

Between the years covered by Open Payments, Dr. Amornmarn received a total of $7,610 from 60 pharmaceutical and/or device companies across 339 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiology - diagnostic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Amornmarn is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 15 Medicare services $7,610 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 43873 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
15
Medicare services
11
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 15 $93 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,610
Total received (2018-2024)
Avg $1,087/year across 7 years
Top 14% in FL for radiology - diagnostic
60
Companies
339
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,148 (93.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$462 (6.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,400
2023
$1,224
2022
$1,498
2021
$1,059
2020
$107
2019
$1,350
2018
$971

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$860
PFIZER INC.
$540
Novocure Inc.
$525
Lilly USA, LLC
$430
Janssen Biotech, Inc.
$417
Seagen Inc.
$405
Incyte Corporation
$341
Astellas Pharma US Inc
$274
Merck Sharp & Dohme LLC
$224
AstraZeneca Pharmaceuticals LP
$224
Celgene Corporation
$204
Bayer HealthCare Pharmaceuticals Inc.
$197
Seattle Genetics, Inc.
$181
Takeda Pharmaceuticals U.S.A., Inc.
$161
Bayer Healthcare Pharmaceuticals Inc.
$160
SOBI, INC
$146
E.R. Squibb & Sons, L.L.C.
$128
GT Medical Technologies, Inc
$125
Gilead Sciences, Inc.
$112
BeiGene USA, Inc.
$107
Brainlab, Inc.
$105
Amgen Inc.
$103
Mirati Therapeutics, Inc.
$95
GENZYME CORPORATION
$90
ABBVIE INC.
$87
Exelixis Inc.
$87
Regeneron Healthcare Solutions, Inc.
$81
Pharmacyclics LLC, An AbbVie Company
$68
Clovis Oncology, Inc.
$66
Eisai Inc.
$65
Alnylam Pharmaceuticals Inc.
$62
Stemline Therapeutics Inc.
$60
TOLMAR Pharmaceuticals, Inc.
$59
ARRAY BIOPHARMA INC
$58
Daiichi Sankyo Inc.
$54
Merck Sharp & Dohme Corporation
$49
EMD Serono, Inc.
$49
MorphoSys, US Inc.
$48
JAZZ PHARMACEUTICALS INC.
$48
Puma Biotechnology, Inc.
$48
Genentech USA, Inc.
$39
Alexion Pharmaceuticals, Inc.
$38
Epizyme, Inc.,
$38
PUMA BIOTECHNOLOGY, INC.
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Sumitomo Pharma America, Inc.
$28
EUSA Pharma (US) LLC
$27
INSYS Therapeutics Inc
$24
TerSera Therapeutics LLC
$23
EISAI INC.
$21
Blueprint Medicines Corporation
$20
Pharmacosmos Therapeutics Inc.
$20
G1 Therapeutics, Inc.
$19
Agios Pharmaceuticals, Inc.
$18
Taiho Oncology, Inc.
$18
ACCORD HEALTHCARE, INC.
$17
AbbVie Inc.
$15
Verity Pharmaceuticals Inc.
$14
Global Blood Therapeutics, Inc.
$13
Deciphera Pharmaceuticals Inc.
$12
Top 3 companies account for 25.3% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · AYVAKIT · BAVENCIO · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CAMCEVI · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIGARD · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Erleada · GIVLAARI · GammaTile · Halaven · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LORBRENA · LUMAKRAS · LUPRON DEPOT · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · Monoferric · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OPDIVO · ORGOVYX · OXBRYTA · Oncology · Optune · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · Padcev · QINLOCK · REBLOZYL · RETEVMO · Revlimid · Rubraca · SUTENT · SYNDROS · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TIBSOVO · TIVDAK · TUKYSA · Trelstar · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · XALKORI · XGEVA · XTANDI · Xtandi · ZEPZELCA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $50,733 per 100 Medicare services performed
Looking for a radiology - diagnostic specialist in Kissimmee?
Compare radiology - diagnostics in the Kissimmee area by procedure volume, costs, and industry payment transparency.
Browse radiology - diagnostics nearby

Geographic Context

Radiology - diagnostics within 10 mi
44
Per 100K population
10.8
County median income
$68,711
Nearest hospital
HCA FLORIDA OSCEOLA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Amornmarn is a clinical cardiology specialist, with low-engagement industry engagement in the top 14% of FL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Amornmarn experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Amornmarn performed 15 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Amornmarn receive payments from pharmaceutical companies?
Yes. Dr. Amornmarn received a total of $7,610 from 60 companies across 339 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amornmarn's costs compare to other radiology - diagnostics in Kissimmee?
Dr. Amornmarn's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amornmarn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →